Breathing rate predicts therapeutic benefits for heart patients

December 21, 2020

Conditions causing arrhythmia are among the most common cardiac conditions. A study headed by Prof. Georg Schmidt of the Technical University of Munich (TUM) has demonstrated for the first time that the nocturnal respiratory rate can help with an important prediction: It is an indicator of whether a defibrillator will help to extend the life of patients with arrhythmia.

Sudden cardiac death is one of the leading causes of mortality in western industrialized countries. It can be prevented by an implantable cardioverter defibrillator (ICD). This automatically detects life-threatening heart rhythms and emits electrical signals to stop them. The guidelines recommend the implantation of ICDs in patients with a significantly weakened pump function of the left ventricle. According to the German Heart Surgery Report, more than 42,000 defibrillators were implanted in Germany in 2018.

However, the effectiveness of implanting ICDs is sometimes questionable. The latest Heart Surgery Report by the German Heart Foundation also notes that the benefits of defibrillator therapy are not as clear-cut as previously believed. Moreover, they are often offset by relatively common complications arising both during and after the implantation procedure.

Predictive value of the nocturnal respiratory rate

Researchers at TUM have now demonstrated that the nocturnal respiratory rate of heart patients - which has hitherto received little attention - can help to predict the success of ICD treatment. Between May 2014 and September 2018 they monitored 1,971 heart patients at 44 European heart centers. 1,363 of the patients received an ICD, while the control group was treated conservatively. The different treatment options were dictated by the varying availability of ICD therapy at the participating European centers. Consequently, the study was non-randomized. However, the resulting distortions were compensated for through sophisticated statistical analysis. The study has now been published in eClinicalMedicine, an open-access journal produced by the renowned journal The Lancet.

In both groups the scientists measured the average nocturnal respiratory rate between midnight and 6 am based on an ECG protocol. The ICD patients had a survival advantage of 31.3 percent over the control group. At the same time, a significant link was seen between a low nocturnal respiratory rate and reduced mortality: ICD patients with a rate below 18 breaths per minute had a 50 percent survival advantage as compared to the control group, while those with a higher nocturnal respiratory rate gained no survival advantage through the defibrillator.

A biosignal hitherto neglected by cardiologists

"The breathing rate has been largely ignored as a biosignal in the field of cardiology," says Prof. Georg Schmidt, the last author of the study, who heads the working group for biosignal processing at TUM's university hospital Klinikum rechts der Isar. "Our conclusions will now place a greater focus on this parameter," says Prof. Schmidt, noting that the study demonstrates the predictive value of breathing frequency for therapeutic efficacy. "Especially in borderline cases, checking the patient's breathing rate can help to decide on the right therapy."

Randomized study needed

Against this backdrop, Schmidt, who also chairs the TUM Ethics Commission, believes that it would be reasonable to aim for a randomized study versus the established guidelines. "This would involve dividing the patients observed to gain no advantage from the ICD in our study into two groups, with one having an ICD implanted and the other receiving conservative treatment. If a randomized study of this kind reveals that heart patients with a higher nocturnal breathing rate do not benefit from the ICD implant, they could be spared this invasive treatment in the future."
-end-
Further information:

The first authors of the study, funded by the European Union, are Michael Dommasch and Alexander Steger of TUM. The study was carried out at 44 centers in 15 countries. Prof. Markus Zabel of Herzzentrum Göttingen organized the Europe-wide set-up. The Department of Medical Statistics at the University of Göttingen, headed by Prof. Tim Friede, provided support with the statistical data management.

Technical University of Munich (TUM)

Related Arrhythmia Articles from Brightsurf:

Machine learning helps pinpoint sources of the most common cardiac arrhythmia
Researchers have designed a new ML-based approach for detecting atrial fibrillation drivers, small patches of the heart muscle that are hypothesized to cause this most common type of cardiac arrhythmia.

Heart regeneration using stem cells: Why irregular heartbeats occur after transplantation
Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo elucidated why arrhythmia occurs post-transplant of hESC-CMs.

Arrhythmia-free survival is indeed survival of the fittest
In a new study, investigators report that patients undergoing atrial fibrillation (AF) ablation, who are physically fit before the procedure, have a much higher chance of benefiting from the procedure and remaining in normal sinus rhythm.

Spectroscopy approach poised to improve treatment for serious heart arrhythmia
Researchers have demonstrated that a new mapping approach based on near infrared spectroscopy can distinguish between fat and muscle tissue in the heart.

Drugs considered for COVID-19 can raise risk for dangerous abnormal heart rhythms
As some consider treating coronavirus patients with a combination of the malaria drug hydroxychloroquine and the antibiotic azithromycin, cardiologists are advising caution because both medications can increase the risk for dangerous abnormal heart rhythms, which can in turn lead to cardiac arrest.

Ultrasound solves an important clinical problem in diagnosing arrhythmia
Columbia Engineering researchers have used an ultrasound technique they pioneered a decade ago -- electromechanical wave imaging (EWI) -- to accurately localize atrial and ventricular cardiac arrhythmias in adult patients in a double-blinded clinical study.

Inherited arrhythmia in young Finnish Leonbergers under investigation
Inherited malignant ventricular arrhythmia is a fairly common disorder among Finnish Leonbergers under three years of age, with the most severe cases potentially resulting in sudden death.

Noninvasive radiation tx offers long-term benefits to pts with high-risk heart arrhythmia
Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than 2 years, offering hope to patients who have exhausted other treatment options.

Proposed gene therapy for a heart arrhythmia, based on models made from patient cells
Researchers at Boston Children's Hospital report creating the first human tissue model of an inherited heart arrhythmia, replicating two patients' abnormal heart rhythms in a dish, and then suppressing the arrhythmia with gene therapy in a mouse model.

Blood pressure and glucose control may prevent common arrhythmia
Blood-pressure and glucose control may be effective in preventing heart block, a common form of arrhythmia, and the subsequent need for a pacemaker, according to a study by researchers at UC San Francisco.

Read More: Arrhythmia News and Arrhythmia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.